Intrauterine Growth Restriction

Intrauterine Growth Restriction (IUGR) or Fetal Growth Restriction (FGR) occurs when a baby in the womb doesn't grow as expected, typically defined as estimated fetal weight below the 10th percentile for gestational age. It can be caused by problems with the placenta (most common), maternal health conditions (hypertension, preeclampsia), infections, genetic factors, or lifestyle factors like smoking. IUGR increases risks for stillbirth, premature birth, and health problems for the baby.

CRITICAL: IUGR requires close medical monitoring throughout pregnancy. Diagnosis is made by ultrasound measuring fetal size and assessing placental blood flow (Doppler studies). Management depends on cause, severity, and gestational age - may include increased monitoring, early delivery if fetal distress, or corticosteroids for lung development if preterm delivery anticipated. Address modifiable risk factors: STOP SMOKING, control blood pressure, treat any underlying conditions. These supplements may support placental function and fetal growth but do not replace medical management. Work closely with your maternal-fetal medicine specialist.

* Omega-3 Fatty Acids (Fish Oil) support placental blood flow and fetal development. Meta-analyses suggest fish oil supplementation may reduce the risk of growth restriction and preterm birth.

* L-Arginine is a nitric oxide precursor that supports blood vessel relaxation and blood flow. Studies show it may improve fetal growth in pregnancies with IUGR, likely by improving placental blood flow.

* Folate is essential for fetal development and healthy placental function. Adequate folate intake throughout pregnancy supports growth.

* Vitamin D deficiency has been associated with increased IUGR risk. Maintaining adequate levels supports placental function and fetal bone development.

* Iron supplementation prevents maternal anemia, which can impair oxygen delivery to the fetus and contribute to growth restriction.

* Zinc is essential for fetal growth and development. Deficiency has been linked to IUGR and poor birth outcomes.

* Coenzyme Q10 supports mitochondrial function and energy production in the placenta.

* Low-Dose Aspirin (prescription) is recommended for women at high risk of preeclampsia and IUGR. It improves placental blood flow and significantly reduces these complications when started early in pregnancy.

Expected timeline: Preventive supplements should be started early in pregnancy (ideally preconception). L-arginine effects on blood flow may be seen within weeks. Fetal growth is monitored by serial ultrasounds.